发明名称 |
DISCRIMINATION OF BLOOD TYPE VARIANTS |
摘要 |
The present invention provides a method for detecting the presence or absence of, or for discriminating between, blood type variants, including RHD*r′s, RHD*DIIIa and RHD*DIVa-2. The method comprises amplifying by PCR a sample obtained from a human subject at intron 3 of the RHD gene locus. The invention also provides products, in particular, probes, primers and kits for use in the method of the invention. |
申请公布号 |
US2014255923(A1) |
申请公布日期 |
2014.09.11 |
申请号 |
US201313791284 |
申请日期 |
2013.03.08 |
申请人 |
PROGENIKA BIOPHARMA S.A. |
发明人 |
Ochoa Jorge;Lopez Monica;Molano Araitz;Tejedor Diego;Martinez Antonio |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
1. An oligonucleotide polymerase chain reaction (PCR) primer, the nucleotide sequence of which is of the formula:
X—Y—Z wherein: X is X1 or X2, wherein:
X1 is the final n nucleotides of the nucleotide sequence ATATGGAAATTTGATCATGT (SEQ ID NO: 1), wherein n is a number between 0 and 20, inclusive; andX2 is a variant of X1 differing by no more than one nucleotide substitution; Y is Y1 or Y2, wherein:
Y1 is the nucleotide sequence AS1TAATS2ATAC (SEQ ID NO: 2), wherein S1 and S2 are independently selected from G and C; andY2 is a variant of Y1 differing from Y1 by no more than one nucleotide substitution, provided that said nucleotide substitution is not a substitution of the first A or final C of Y1; Z is the first m nucleotides in the nucleotide sequence TAAAG, wherein m is a number between 0 and 5, inclusive. |
地址 |
Derio ES |